Literature DB >> 22350104

Would some cannabinoids ameliorate symptoms of autism?

Rami Bou Khalil.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22350104     DOI： 10.1007/s00787-012-0255-z

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN： 1018-8827            Impact factor:   4.785


× No keyword cloud information.
  9 in total

Review 1.  Autism and oxytocin: new developments in translational approaches to therapeutics.

Authors:  Joshua J Green; Eric Hollander
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

Review 2.  Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine.

Authors:  Andreas Meyer-Lindenberg; Gregor Domes; Peter Kirsch; Markus Heinrichs
Journal:  Nat Rev Neurosci       Date:  2011-08-19       Impact factor: 34.870

3.  Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism.

Authors:  Mariaelvina Sala; Daniela Braida; Daniela Lentini; Marta Busnelli; Elisabetta Bulgheroni; Valeria Capurro; Annamaria Finardi; Andrea Donzelli; Linda Pattini; Tiziana Rubino; Daniela Parolaro; Katsuhiko Nishimori; Marco Parenti; Bice Chini
Journal:  Biol Psychiatry       Date:  2011-02-21       Impact factor: 13.382

4.  Impaired nociception and pain sensation in mice lacking the capsaicin receptor.

Authors:  M J Caterina; A Leffler; A B Malmberg; W J Martin; J Trafton; K R Petersen-Zeitz; M Koltzenburg; A I Basbaum; D Julius
Journal:  Science       Date:  2000-04-14       Impact factor: 47.728

5.  Promoting social behavior with oxytocin in high-functioning autism spectrum disorders.

Authors:  Elissar Andari; Jean-René Duhamel; Tiziana Zalla; Evelyn Herbrecht; Marion Leboyer; Angela Sirigu
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-16       Impact factor: 11.205

Review 6.  Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders.

Authors:  Caterina Scuderi; Daniele De Filippis; Teresa Iuvone; Angelo Blasio; Antonio Steardo; Giuseppe Esposito
Journal:  Phytother Res       Date:  2009-05       Impact factor: 5.878

7.  Discrete expression of TRPV2 within the hypothalamo-neurohypophysial system: Implications for regulatory activity within the hypothalamic-pituitary-adrenal axis.

Authors:  Anna Wainwright; A Richard Rutter; Guy R Seabrook; Kathryn Reilly; Kevin R Oliver
Journal:  J Comp Neurol       Date:  2004-06-14       Impact factor: 3.215

8.  TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons.

Authors:  Ning Qin; Michael P Neeper; Yi Liu; Tasha L Hutchinson; Mary Lou Lubin; Christopher M Flores
Journal:  J Neurosci       Date:  2008-06-11       Impact factor: 6.167

9.  Consequences of cannabinoid and monoaminergic system disruption in a mouse model of autism spectrum disorders.

Authors:  E S Onaivi; R Benno; T Halpern; M Mehanovic; N Schanz; C Sanders; X Yan; H Ishiguro; Q-R Liu; A L Berzal; M P Viveros; S F Ali
Journal:  Curr Neuropharmacol       Date:  2011-03       Impact factor: 7.363
  9 in total
  1 in total

1.  Cannabinoid Receptors and Ligands: Lessons from CNS Disorders and the Quest for Novel Treatment Venues.

Authors:  Clara M Vecchini Rodríguez; Yma Escalona Meléndez; Jacqueline Flores-Otero
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.